NANOSONO Overview
NANOSONO is a bio-tech company that develops an antimicrobial platform that can give any surface the power to destroy bacteria instantly and continuously. The company's integrated technology can transform almost any material or surface into an "antimicrobial firewall" by charging it with the antimicrobial powers of nanotechnology. This "firewall" becomes active instantly and, unlike other antimicrobial technology, stays active permanently, providing safe, continuous protection with no need to re-coat or re-apply. The company's always-on antimicrobial shield can be integrated into a wide range of applications.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Everlasting Germ Killer, In Paint, Fabric, Plastic And More
Israeli startup Nanosono has developed nanoparticles made of zinc oxide and copper oxide that can kill up to 99.999% of bacteria and viruses. The nanoparticles, known as Quactiv, can be incorporated into various materials such as paint, fabric, and plastic, providing long-lasting antimicrobial protection. The company has expanded its applications beyond paint and is now developing products for clinical environments, including bed sheets, surgical drapes, facemasks, and bandages. Nanosono has signed commercial agreements with paint, coating, cosmetic, and textile companies and is targeting markets in the US, Europe, China, and India. The company is also exploring future applications in other materials and industries, such as coatings for stone and marble surfaces and even spaceships.
CustomersPartners
growth-positive
Israeli nanotechnology startup Nanosono nets $2 million from Gadot Group | CTech
Israeli startup Nanosono has signed a strategic agreement with Gadot Group, a chemical production and logistics company. Gadot Group will invest $2 million in Nanosono and build the necessary infrastructure and production line for Nanosonos antimicrobial technology. The collaboration aims to integrate Nanosonos QUACTIV technology in various applications. Nanosono has raised $21 million to date, with investors including the U.S.-based AHG Group and Dr. Michael Mirilashvili. The agreement aligns with Nanosonos strategy to focus on developing future technologies to fight infections and establish collaborations with leading chemical companies.
PartnersInvestment
growth-positive
Israel's Nanosono receives investment from Turkey-based ODAS
Israeli nanotechnology company Nanosono has entered into a significant cooperation agreement with Turkish company ODAS. ODAS will invest in Nanosonos antibacterial and antiviral technologies and together they will build a factory in Turkey to produce antibacterial fabrics and textiles. The investment amount was not disclosed but is expected to be in the millions of dollars. The coated fabrics will be marketed by both companies in Israel, Asia Pacific, and Europe. Nanosono aims to become a leading global player in the antibacterial textile market. The partnership is seen as a significant milestone in Nanosonos business growth. Nanosono has raised $14 million to date and expects its value to reach $100 million by the end of 2022.
PartnersInvestment
| Sector | Industrial Technologies |
Funding
| Total funding | $16M |
| Last funding | $2M |
| Stage | Seed |
| Rounds | 5 |
| Investors | 2 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | www.nanosono.com |
| Careers | Careers page |
Locations
HaKidma Street 7, Yokneam, Israel
Photos & Videos
1 item(s)
